MFDS
- Status: likely_approved
🇰🇷 Saphnelo in South Korea
Saphnelo (ANIFROLUMAB) regulatory status in South Korea.
Marketing authorisation
Saphnelo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Saphnelo approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Saphnelo in South Korea?
AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.